Milnacipran Study Identifies Which Fibromyalgia Patients Benefit

People with high pain and low anxiety and no major sleep problems benefit

  1. Cort
    Resource Type:
    Report or Study
    We should be seeing more of these studies over time. This data mining study found that one type of FM patient - people with
    • high pain levels
    • low anxiety or catastrophizing
    • no major sleep problems, absence of major sleeping problems
    • physical limitations in the daily life effort

    benefited most from milnacipran (Savella) - an FDA approved drug for FM. That's important because only a subset of patients benefit.